All translations
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | ==Drug comparison and pharmacokinetics== {| class="wikitable" border="1" |+ Table 1: Comparison of ARB [[pharmacokinetics]] |- ! Drug ! Biological half-life [h] ! Protein binding [%] ! Bioavailability [%] ! Renal/hepatic [[Clearance (medicine)|clearance]] [%] ! Food effect ! Daily dosage [mg] |- | [[Losartan]] | 2 | 98.7 | 33 | 10/90 | Minimal | 50-100 |- | [[EXP 3174]] | 6-9 | 99.8 | - | 50/50 | - | - |- | [[Candesartan]] | 9 | >99 | 15 | 60/40 | No | 4-32 |- | [[Valsartan]] | 6 | 95 | 25 | 30/70 | 40-50% decreased by | 80-320 |- | [[Irbesartan]] | 11-15 | 90-95 | 70 | 1/99 | No | 150-300 |- | [[Telmisartan]] | 24 | >99 | 42-58 | 1/99 | No | 40-80 |- | [[Eprosartan]] | 5 | 98 | 13 | 30/70 | No | 400-800 |- | [[Olmesartan]] | 14-16 | >99 | 29 | 40/60 | No | 10-40 |- | colspan="7" style="text-align: center;" |Sources: |} |
| h Japanese (ja) | ==薬物の比較と薬物動態== {{Anchor|Drug comparison and pharmacokinetics}} {| class="wikitable" border="1" |+ 表1：ARB[[pharmacokinetics/ja|薬物動態]]の比較 |- ! 薬剤 ! 生物学的半減期 [h] ! タンパク質結合率 [%] ! 生物学的利用能 [%] ! 腎/肝[[Clearance (medicine)/ja|クリアランス]] [%] ! 食物の影響 ! 容量/日 [mg] |- | [[Losartan/ja]] | 2 | 98.7 | 33 | 10/90 | ミネラル | 50-100 |- | [[EXP 3174/ja]] | 6-9 | 99.8 | - | 50/50 | - | - |- | [[Candesartan/ja]] | 9 | >99 | 15 | 60/40 | No | 4-32 |- | [[Valsartan/ja]] | 6 | 95 | 25 | 30/70 | 40-50% 減少 | 80-320 |- | [[Irbesartan/ja]] | 11-15 | 90-95 | 70 | 1/99 | なし | 150-300 |- | [[Telmisartan/ja]] | 24 | >99 | 42-58 | 1/99 | なし | 40-80 |- | [[Eprosartan/ja]] | 5 | 98 | 13 | 30/70 | なし | 400-800 |- | [[Olmesartan/ja]] | 14-16 | >99 | 29 | 40/60 | なし | 10-40 |- | colspan="7" style="text-align: center;" |情報源: |} |